2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Clinical Lung Cancer CLIN LUNG CANCER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.2
51人评分
我要评分
声誉 8.7 影响力 6.1 速度 6.9 | |||||||||||||||||||||||||
| 期刊ISSN | 1525-7304 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||
| E-ISSN | 1938-0690 | |||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 3.3 点击查看影响因子趋势图 | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：3.78 | |||||||||||||||||||||||||
| 2024-2025自引率 | 3.0%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年影响因子 | 3.3 | |||||||||||||||||||||||||
| JCI期刊引文指标 | 0.78 | |||||||||||||||||||||||||
| h-index | 52 | |||||||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://www.clinical-lung-cancer.com/ | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/CLC | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Thoracic Radiotherapy and Radiation Time Would Affect the Efficacy of Advanced Non-Small Cell Lung Cancer for Patients Who Responded to TKIs Treatment Author: Ma, Jinbo; Li, Cheng; Wang, Xiao; Zhang, Pengfei; Ma, Xiaoyan; Kan, Hongxing; Zhang, Wei Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 126-134. DOI: 10.1016/j.clc.2025.12.009 TIGOS Trial: A Randomized, Double-Blind , Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer Author: Paz-Ares, Luis G.; O'Byrne, Kenneth John; Johnson, Melissa L.; Reck, Martin; Girard, Nicolas; Hayashi, Hidetoshi; Zhou, Caicun; Gharpure, Vishwanath Suresh; Pisupati, Radhika; Pacius, Misena; Ready, Neal E Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 140-145. DOI: 10.1016/j.clc.2026.01.009 Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations Author: Liu, Zetao; Peng, Zhiyu; Cao, Jie; Huang, Zhaokang; Liao, Xizhou; Zong, Xiaorong; Guo, Chenglin; Mei, Jiandong Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 177-188. DOI: 10.1016/j.clc.2025.09.001 Anaplastic Lymphoma Kinase Rearrangement and Tumor Spread Through Air Spaces Is Associated with Worse Clinical Outcomes for Resected Stage IA Lung Adenocarcinoma Author: Shi, Jinghan; Xu, Kuan; Liu, Xufeng; Shi, Minjun; Ji, Chunyu; Ye, Bo Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 151-160. DOI: 10.1016/j.clc.2025.08.016 | |||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Clinical Lung Cancer的语言要求，还能让Clinical Lung Cancer编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Clinical Lung Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | CIG MEDIA GROUP, LP, 3500 MAPLE AVENUE, STE 750, DALLAS, USA, TX, 75219-3931 | |||||||||||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||||||||||
| 出版年份 | 1999 | |||||||||||||||||||||||||
| 年文章数 | 144点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 14.62% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.75% | |||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：2区
| |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-7304%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Clinical Lung Cancer顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Thoracic Radiotherapy and Radiation Time Would Affect the Efficacy of Advanced Non-Small Cell Lung Cancer for Patients Who Responded to TKIs Treatment Author: Ma, Jinbo; Li, Cheng; Wang, Xiao; Zhang, Pengfei; Ma, Xiaoyan; Kan, Hongxing; Zhang, Wei Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 126-134. DOI: 10.1016/j.clc.2025.12.009 PubMed DOI |
| 2. | TIGOS Trial: A Randomized, Double-Blind , Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer Author: Paz-Ares, Luis G.; O'Byrne, Kenneth John; Johnson, Melissa L.; Reck, Martin; Girard, Nicolas; Hayashi, Hidetoshi; Zhou, Caicun; Gharpure, Vishwanath Suresh; Pisupati, Radhika; Pacius, Misena; Ready, Neal E Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 140-145. DOI: 10.1016/j.clc.2026.01.009 PubMed DOI |
| 3. | Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations Author: Liu, Zetao; Peng, Zhiyu; Cao, Jie; Huang, Zhaokang; Liao, Xizhou; Zong, Xiaorong; Guo, Chenglin; Mei, Jiandong Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 177-188. DOI: 10.1016/j.clc.2025.09.001 PubMed DOI |
| 4. | Anaplastic Lymphoma Kinase Rearrangement and Tumor Spread Through Air Spaces Is Associated with Worse Clinical Outcomes for Resected Stage IA Lung Adenocarcinoma Author: Shi, Jinghan; Xu, Kuan; Liu, Xufeng; Shi, Minjun; Ji, Chunyu; Ye, Bo Journal: CLINICAL LUNG CANCER. 2026; Vol. 27, Issue 2, pp. 151-160. DOI: 10.1016/j.clc.2025.08.016 PubMed DOI |
| 5. | Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review Author: Yeung, Anson Man Lok; Chung, James; Chow, Hang Journal: CLINICAL LUNG CANCER. 2026; Vol. 87, Issue 2, pp. 85-97. DOI: 10.1016/j.clc.2026.01.003 PubMed DOI |
| 6. | Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non-Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters Author: Zhang, Ying; Zhou, Shi-Hong; Yan, Yu-Jie; Wu, Lei-Lei; Yuan, Xiao-Shuai; Hu, Min; Kang, Jing-Jing; Jiang, Chen-Xue; Zhu, Yao-Yao; Yang, Shuang-Yan; Zhao, Rui-Feng; Hu, Jian; Hu, Min-Ren; Liu, Hui; Liu, Liang; Zhao, Lan; Xu, Ya-Ping Journal: CLINICAL LUNG CANCER. 2025; Vol. 26, Issue 5, pp. 393-406. DOI: 10.1016/j.clc.2025.02.009 PubMed DOI |
| 7. | Prognostic Implications of Lymph Node Status in Non-Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study Author: Ma, Ran; Yang, Haitang; Ge, Yong; Ma, Tianyue; Wang, Jiayi; Li, Shuyuan; Feng, Tianci; Feng, Shoujie; Zhang, Cheng; Sun, Teng; Yao, Feng; Yi, Jun; Zhang, Hao; Song, Pingping Journal: CLINICAL LUNG CANCER. 2025; Vol. 26, Issue 5, pp. 370-383. DOI: 10.1016/j.clc.2025.04.004 PubMed DOI |
| 8. | Induction Immunochemotherapy Followed by Hypo-Fractionated Radiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Author: Zhu, Zihao; Wu, Jianfeng; Zhao, Lijun; Jiang, Ning; Chen, Yu; Song, Xue; Li, Ming; Jiang, Ming; Shi, Meiqi; Yu, Shaorong; Ren, Binhui; Yin, Rong; Jiang, Feng; Wang, Li; Kong, Cheng; Zhu, Xiangzhi Journal: CLINICAL LUNG CANCER. 2025; Vol. 26, Issue 4, pp. -. DOI: 10.1016/j.clc.2025.01.012 DOI |
| 9. | PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System Disease Author: Lu, Chang; Yan, Hong-Hong; Zhang, Chan-Yuan; Chen, Shi-Yuan; Li, Yang-Si; Wang, Bin-Chao; Xu, Chong-Rui; Tu, Hai-Yan; Zhong, Wen-Zhao; Zhou, Qing; Zhang, Xu-Chao; Wu, Yi-Long; Feng, Wei-Neng; Jiang, Guan-Ming; Yang, Jin-Ji Journal: CLINICAL LUNG CANCER. 2025; Vol. 26, Issue 4, pp. 263-266. DOI: 10.1016/j.clc.2024.12.002 PubMed DOI |
| 10. | Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series Author: Le, Xiuning; Eisert, Anna; Hsia, Te-Chun; Raut, Nirmal Vivek; Ahmad, Azura; Chan, Oscar Siu Hong; De Bondt, Charlotte; Farrugia, David; Froesch, Patrizia; Gonzalez-Cao, Maria; Hendriks, Lizza; Hochmair, Maximillian J.; Mazieres, Julien; O'Sullivan, Hazel; Popat, Sanjay; Samol, Jens; van der Wekken, Anthonie J.; Yang, Tsung-Ying; Tho, Lye Mun; Himpe, Ulrike; Lam, Wei-Sen; Lee, Kirsty Wai Chung; Petrini, Iacopo; Berghoff, Karin; Karachaliou, Niki; Oshi, Kirti J.; Vlassak, Soetkin; Chang, Gee-Chen Journal: CLINICAL LUNG CANCER. 2025; Vol. 26, Issue 4, pp. -. DOI: 10.1016/j.clc.2025.02.013 DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共68条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
